Treatment of recurrent depression

References

• Judd LL. The clinical course of unipolar major depressive disorders. Arch. Gen. Psychiatry54, 989–991 (1997).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). American Psychiatric Association, DC, USA (1994).
   Google Scholar
• Fava GA, Fabbri S, Sonino N. Residual symptoms in depression: an emerging therapeutic target. Progr. Neuropsychopharmacol. Biol. Psychiatry26, 1019–1027 (2002).
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Sonino N. Treatment of recurrent depression. CNS Drugs17, 1109–1117 (2003).
   PubMed Web of Science ®Google Scholar
• Bech P. Social functioning: should it become an endpoint in trials of antidepressants? CNS Drugs19, 313–324 (2005).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry157(Suppl.), 1–45 (2000).
   Google Scholar
• Schulberg HC, Katon W, Simon GE, Rush AJ. Treating major depression in primary care practice. Arch. Gen. Psychiatry55, 1121–1127 (1998).
   PubMed Web of Science ®Google Scholar
• Ellis PM, Smith DAR. Treating depression: the beyond blue guidelines for treating depression in primary care. Med. J. Aust.176(Suppl. 10), S77–S83 (2002).
   Google Scholar
• Geddes JR, Carney SM, Davies C et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet361, 653–661 (2003).
   PubMed Web of Science ®Google Scholar
• Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J. Clin. Epidemiol.53, 207–216 (2000).
   PubMed Web of Science ®Google Scholar
• Otto MW, Nierenberg AA. Assay sensitivity, failed trials, and the conduct of science. Psychother. Psychosom.71, 241–243 (2002).
   PubMed Web of Science ®Google Scholar
• Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harvard Rev. Psychiatry5, 293–306 (1998).
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Ghaemi SN, Viguera AC. Tolerance in antidepressant treatment. Psychother. Psychosom.71, 177–179 (2002).
   PubMed Web of Science ®Google Scholar
• Andrews G. Should depression be managed as a chronic disease? Br. Med. J.322, 419–421 (2001).
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Mangelli L. Patients can be taught how to improve recovery. Br. Med. J.322, 1428 (2001).
   PubMed Web of Science ®Google Scholar
• Fava GA. Can long-term treatment with antidepressant drugs worsen the course of depression? J. Clin. Psychiatry64, 123–133 (2003).
   PubMed Web of Science ®Google Scholar
• Schmidt ME, Fava M, Zhang S et al. Treatment approaches to major depressive disorder relapse. Part 1: dose increase. Psychother. Psychosom.71, 190–194 (2002).
   PubMed Web of Science ®Google Scholar
• Solomon DA, Leon AC, Mueller TI et al. Tachyphylaxis in unipolar major depressive disorder. J. Clin. Psychiatry66, 283–290 (2005).
   PubMed Web of Science ®Google Scholar
• Sharma V. Loss of response to antidepressants and subsequent refractoriness. J. Affect. Disord.64, 99–106 (2001).
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Perel JM et al. Comparison of full dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J. Affect. Disord.27, 139–145 (1993).
   PubMed Web of Science ®Google Scholar
• Davis JM, Janicak PG, Hogan DM. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr. Scand.100, 406–417 (1999).
   PubMed Web of Science ®Google Scholar
• Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology98, 535–538 (1989).
   PubMed Web of Science ®Google Scholar
• Kupfer DJ, Frank E, Perel JM. The advantage of early treatment intervention in recurrent depression. Arch. Gen. Psychiatry46, 771–775 (1989).
   PubMed Web of Science ®Google Scholar
• Claxton AJ, Zhiming L, McKendrik J. Selective serotonin reuptake inhibitor treatment in the UK. Br. J. Psychiatry177, 163–168 (2000).
   PubMed Web of Science ®Google Scholar
• Fava M, Schmidt ME, Zhang S, Gonzales J, Rank NJ, Judge R. Treatment approaches to major depressive dosorder relapse. Part II: re-initiation of antidepressant treatment. Psychother. Psychosom.71, 155–199 (2002).
   Google Scholar
• Fava GA, Ruini C, Rafanelli C. Sequential treatment of mood and anxiety disorders. J. Clin. Psychiatry66, 1392–1400 (2005).
   PubMed Web of Science ®Google Scholar
• Lau MA, McCain SF. Integrating mindfulness meditation with cognitive and behavioural therapies. Can. J. Psychiatry50, 863–869 (2005).
   PubMed Web of Science ®Google Scholar
• Otto MW, Smits JAJ, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults. Can. J. Psychiatry12, 72–86 (2005).
   Google Scholar
• Keller MB, McCullough JP, Klein DN et al. A comparison of nefazodone, the cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med.342, 1462–1470 (2000).
   PubMed Web of Science ®Google Scholar
• TADS Team. Fluoxetine, cognitive behavioral therapy, and their combination for adolescents with depression. JAMA292, 807–820 (2004).
   PubMed Web of Science ®Google Scholar
• Hollon S, de Rubeis RJ, Shelton RC et al. Prevention of relapse following cognitive therapy versus medications in moderate to severe depression. Arch. Gen. Psychiatry62, 417–422 (2005).
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am. J. Psychiatry161, 1872–1876 (2004).
   PubMed Web of Science ®Google Scholar
• Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy in outpatients with recurrent depression. Br. J. Psychiatry171, 328–334 (1997).
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med.344, 1343–1356 (2001).
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement based care in STAR-D. Am. J. Psychiatry163, 28–40 (2006).
   PubMed Web of Science ®Google Scholar
• Fava M, Rush AJ. Current status of augmentation and combination treatments for major depressive disorder. Psychother. Psychosom.75, 139–153 (2006).
   PubMed Web of Science ®Google Scholar
• Posternak MA, Zimmerman M. Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors. J. Clin. Psychiatry66, 704–707 (2005).
   Google Scholar
• Bodnar LM, Wisner KL. Nutrition and depression. Biol. Psychiatry58, 679–685 (2005).
   PubMed Web of Science ®Google Scholar
• Williams A, Katz D, Ali A et al. Do essential fatty acids have a role in the treatment of depression? J. Affect. Disord.93, 117–123 (2006).
   PubMed Web of Science ®Google Scholar
• Layard R. The case for psychological treatment centres. Br. Med. J.332, 1030–1032 (2006).
   PubMed Web of Science ®Google Scholar